Literature DB >> 31689414

Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.

Priya Agarwala1, Steve H Salzman2.   

Abstract

The 6-min walk test (6MWT) is a commonly used test for the objective assessment of functional exercise capacity for the management of patients with moderate-to-severe pulmonary disease. Unlike pulmonary function testing, the 6MWT captures the often coexisting extrapulmonary manifestations of chronic respiratory disease, including cardiovascular disease, frailty, sarcopenia, and cancer. In contrast with cardiopulmonary exercise stress testing, this test does not require complex equipment or technical expertise. In this low complexity, safe test, the patient is asked to walk as far as possible along a 30-m minimally trafficked corridor for a period of 6 min with the primary outcome measure being the 6-min walk distance (6MWD) measured in meters. There has been interest in other derived indexes, such as distance-desaturation product (the product of nadir oxygen saturation and walk distance), which in small studies has been predictive of morbidity and mortality in certain chronic respiratory conditions. Special attention to methodology is required to produce reliable and reproducible results. Factors that can affect walk distance include track layout (continuous vs straight), track length, oxygen amount and portability, learning effect, and verbal encouragement. The absolute 6MWD and change in 6MWD are predictive of morbidity and mortality in patients with COPD, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis and patients awaiting lung transplant, highlighting its use in management decisions and clinical trials. As of January 2018, Current Procedural Terminology code 94620 (simple pulmonary stress test) has been deleted and replaced by two new codes, 94617 and 94618. Code 94617 includes exercise test for bronchospasm including pre- and postspirometry, ECG recordings, and pulse oximetry. Code 94618, pulmonary stress testing (eg, 6MWT), includes the measurement of heart rate, oximetry, and oxygen titration when performed. If 94620 is billed after January 2018 it will not be reimbursed.
Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Keywords:  6-min walk distance; 6-min walk test; COPD; current procedural terminology; exercise pulse oximetry; fee schedule; idiopathic pulmonary fibrosis; physician reimbursement; pulmonary hypertension

Mesh:

Year:  2019        PMID: 31689414      PMCID: PMC7609960          DOI: 10.1016/j.chest.2019.10.014

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  59 in total

1.  Learning from the learning effect in the six-minute-walk test.

Authors:  Divay Chandra; Hrishikesh S Kulkarni; Frank Sciurba
Journal:  Am J Respir Crit Care Med       Date:  2012-03-15       Impact factor: 21.405

2.  Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test?

Authors:  Cb Fiore; Al Lee; Cf McDonald; Cj Hill; Ae Holland
Journal:  Chron Respir Dis       Date:  2011       Impact factor: 2.444

3.  Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

Authors:  Kevin R Flaherty; Adin-Cristian Andrei; Susan Murray; Chris Fraley; Thomas V Colby; William D Travis; Vibha Lama; Ella A Kazerooni; Barry H Gross; Galen B Toews; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2006-07-06       Impact factor: 21.405

Review 4.  The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis.

Authors:  A Whitney Brown; Steven D Nathan
Journal:  Ann Am Thorac Soc       Date:  2018-01

Review 5.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.

Authors:  Anne E Holland; Martijn A Spruit; Thierry Troosters; Milo A Puhan; Véronique Pepin; Didier Saey; Meredith C McCormack; Brian W Carlin; Frank C Sciurba; Fabio Pitta; Jack Wanger; Neil MacIntyre; David A Kaminsky; Bruce H Culver; Susan M Revill; Nidia A Hernandes; Vasileios Andrianopoulos; Carlos Augusto Camillo; Katy E Mitchell; Annemarie L Lee; Catherine J Hill; Sally J Singh
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

6.  Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Amy L Olson; Oksana A Shlobin; Shahzad Ahmad; Kevin K Brown; Steven D Nathan
Journal:  Respirology       Date:  2011-04       Impact factor: 6.424

7.  Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length.

Authors:  Frank Sciurba; Gerard J Criner; Shing M Lee; Zab Mohsenifar; David Shade; William Slivka; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

8.  Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.

Authors:  Gérald Simonneau; Lewis J Rubin; Nazzareno Galiè; Robyn J Barst; Thomas R Fleming; Adaani Frost; Peter Engel; Mordechai R Kramer; Marjana Serdarevic-Pehar; Gary R Layton; Olivier Sitbon; David B Badesch
Journal:  J Heart Lung Transplant       Date:  2014-02-22       Impact factor: 10.247

Review 9.  Predictors of Survival in COPD: more than just the FEV1.

Authors:  Bartolome R Celli; Claudia G Cote; Suzanne C Lareau; Paula M Meek
Journal:  Respir Med       Date:  2008-06       Impact factor: 3.415

10.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

Authors:  Toru Oga; Koichi Nishimura; Mitsuhiro Tsukino; Susumu Sato; Takashi Hajiro
Journal:  Am J Respir Crit Care Med       Date:  2002-11-21       Impact factor: 21.405

View more
  32 in total

Review 1.  Rate adaptive pacing in people with chronic heart failure increases peak heart rate but not peak exercise capacity: a systematic review.

Authors:  H I Clark; M J Pearson; N A Smart
Journal:  Heart Fail Rev       Date:  2022-02-09       Impact factor: 4.214

2.  Effects of Interactive Dynamic Scalp Acupuncture on Motor Function and Gait of Lower Limbs after Stroke: A Multicenter, Randomized, Controlled Clinical Trial.

Authors:  Shao-Hua Zhang; Yu-Long Wang; Chun-Xia Zhang; Chun-Ping Zhang; Peng Xiao; Qian-Feng Li; Wei-Rong Liang; Xiao-Hua Pan; Ming-Chao Zhou
Journal:  Chin J Integr Med       Date:  2021-12-15       Impact factor: 1.978

3.  Predictors of Adverse Outcomes in Healthy Aging Adults: Coronary Artery Disease, Lower Educational Status and Higher P-Selectin Levels.

Authors:  Agnieszka Batko-Szwaczka; Tomasz Francuz; Agnieszka Kosowska; Anna Cogiel; Joanna Dudzińska-Griszek; Krzysztof Wilczyński; Beata Hornik; Magdalena Janusz-Jenczeń; Iwona Włodarczyk; Bartosz Wnuk; Joanna Szołtysek; Jacek Durmała; Jan Dulawa; Jan Szewieczek
Journal:  Clin Interv Aging       Date:  2022-08-05       Impact factor: 3.829

4.  Assessment of Six-Minute Walk Test Among Discharge-Ready Severe COVID-19 Patients: A Cross-Sectional Study.

Authors:  Uday Yanamandra; Puneet Saxena; Rajagopal Srinath; Anuradha Sawant; Anurag Singh; Nupur Aggarwal; Bareedu Pavan; Gayatri Duhan; Bhavya Aggarwal; Praneet Kaur
Journal:  Cureus       Date:  2022-05-18

5.  Can Proxy Ratings Supplement Patient Report to Assess Functional Domains Among Hospitalized Patients?

Authors:  David J Weiss; Chun Wang; King Yiu Suen; Jeffrey Basford; Andrea Cheville
Journal:  Arch Phys Med Rehabil       Date:  2021-10-20       Impact factor: 4.060

6.  Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion.

Authors:  Susanna B Park; Stefano Tamburin; Angelo Schenone; Ian R Kleckner; Roser Velasco; Paola Alberti; Grace Kanzawa-Lee; Maryam Lustberg; Susan G Dorsey; Elisa Mantovani; Mehrnaz Hamedani; Andreas A Argyriou; Guido Cavaletti; Ahmet Hoke
Journal:  Expert Rev Neurother       Date:  2022-01-11       Impact factor: 4.287

7.  Mixed-dust pneumoconiosis in a dental technician: a multidisciplinary diagnosis case report.

Authors:  Luigi Di Lorenzo; Francesco Inchingolo; Antonella Pipoli; Antonio Di Lorenzo; Alessio Danilo Inchingolo; Gianna Dipalma; Filippo Cassano; Maria Elena Maggiore; Angelo Michele Inchingolo; Sabino Ceci; Assunta Patano; Giuseppina Malcangi; Antonio Mancini; Giosi Longo; Rossella Attimonelli; Eugenio Maiorano; Rocco Laviano; Nicola Mariano Manghisi; Antonio Scarano; Felice Lorusso
Journal:  BMC Pulm Med       Date:  2022-04-27       Impact factor: 3.320

Review 8.  Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations.

Authors:  Rossella Parini; Federica Deodato
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

9.  Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis.

Authors:  Mingming Deng; Yan Yin; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

10.  The Impact of Functional Bars and Adapted Physical Activity on Quality of Life in Chronic Kidney Disease: A Pilot Study.

Authors:  Elisa Grazioli; Eliana Tranchita; Giulia Marrone; Silvia Urciuoli; Manuela Di Lauro; Claudia Cerulli; Nicolò Piacentini; Arianna Murri; Roberto Celotto; Annalisa Romani; Attilio Parisi; Nicola Di Daniele; Annalisa Noce
Journal:  Int J Environ Res Public Health       Date:  2022-03-10       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.